CN103520396B - Mouthwash used for preventing infection after oral implant rehabilitation - Google Patents
Mouthwash used for preventing infection after oral implant rehabilitation Download PDFInfo
- Publication number
- CN103520396B CN103520396B CN201310521875.1A CN201310521875A CN103520396B CN 103520396 B CN103520396 B CN 103520396B CN 201310521875 A CN201310521875 A CN 201310521875A CN 103520396 B CN103520396 B CN 103520396B
- Authority
- CN
- China
- Prior art keywords
- parts
- herb
- herba
- mouthwash
- radix
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention elates to a mouthwash used for preventing infection after oral implant rehabilitation. The mouthwash is prepared from the substances of, by weight: stiffleaf meliosma fruit, common ducksmeat herb, acute sida leaf or root, penduliflory elsholtzia herb, dandelion, fragrant eupatorium herb, Indian stringbush root, rauvolfia verticillata, rhubarb herb, Shanqingpi herb, horseweed herb, and water. The mouthwash provided by the invention has significant effects in treating symptoms such as nausea after oral operation and in preventing wound infection. Postoperative complications do not occur to patients taken the mouthwash, and a clinical treatment effect is clear.
Description
Technical field
The present invention relates to field, oral cavity, specifically, the present invention relates to a kind of for preventing the collutory of oral implant rehabilitation postoperative infection.
Background technology
The infection of wound is easily there is after oral implant rehabilitation.Be at present preventive means mainly with taking the Western medicine with antiinflammation clinically.But oral implant rehabilitation generally all uses anaesthetic, anaesthetic effect hour after surgery, patient often has the symptoms such as nauseating.This situation is not simply use Western medicine just soluble.Therefore need clinically a kind of not only can prevention infection but also the medicine of some ill symptomses of Post operation can be eliminated.
Collutory, as a kind of liquid preparation, has easy to use, curative effect advantage rapidly.If can be applied to prevent infection after mouth operation, then can solve some difficult problems run into when participating in the cintest to a great extent.
Summary of the invention
The object of this invention is to provide a kind of for preventing the collutory of oral implant rehabilitation postoperative infection.
In order to realize object of the present invention, the invention provides a kind of for preventing the collutory of oral implant rehabilitation postoperative infection, it is made up of the material of following weight proportioning: Cortex Meliosmatis rigidae Radicis 4 ~ 12 parts, 5 ~ 15 parts, Herba Spirodelae, Radix sidae acutae 3 ~ 15 parts, Herba Elsholtziae penduliforare 3 ~ 15 parts, Herba Taraxaci 4 ~ 12 parts, Herba Eupatorii Odorati 6 ~ 9 parts, Radix Wikstroemae 1 ~ 5 part, Rauvolfia verticillata 8 ~ 10 parts, Radix Et Rhizoma Rhei 7 ~ 10 parts, 7 ~ 9 parts, mountain Pericarpium Citri Reticulatae Viride, Conyza canadensis (L.) Cronq. 1 ~ 5 part and water 50-100 part.
Preferably, collutory of the present invention is made up of the material of following weight proportioning: Cortex Meliosmatis rigidae Radicis 8 parts, 10 parts, Herba Spirodelae, Radix sidae acutae 7 parts, Herba Elsholtziae penduliforare 7 parts, Herba Taraxaci 8 parts, Herba Eupatorii Odorati 7 parts, Radix Wikstroemae 3 parts, Rauvolfia verticillata 9 parts, Radix Et Rhizoma Rhei 8 parts, 8 parts, mountain Pericarpium Citri Reticulatae Viride, Conyza canadensis (L.) Cronq. 3 parts and 80 parts, water.
With reference to " Chinese medicine voluminous dictionary " second edition, being described as follows of the crude drug used in the present invention:
Chinese medicine has stronger organic conception.Often can be treated from the feature of entire patient, and be not just confined to focus itself.For the patient after operation on oral cavity, except will preventing wound infection, also need to eliminate various post-operative complication, such as, feel sick.These effects are all that Western medicine is beyond one's reach.Simultaneously collutory is as liquid preparation, and onset is quick, and successful, after taking collutory of the present invention, not only has no postoperative wound infection, and patient such as not obviously to be sick in the stomach at the sensation, and clinical efficacy is definite.
Detailed description of the invention
Following examples for illustration of the present invention, but are not used for limiting the scope of the invention.
The preparation of embodiment 1 collutory of the present invention
Get Cortex Meliosmatis rigidae Radicis 80 grams, 100 grams, Herba Spirodelae, Radix sidae acutae 70 grams, Herba Elsholtziae penduliforare 70 grams, Herba Taraxaci 80 grams, Herba Eupatorii Odorati 70 grams, Radix Wikstroemae 30 grams, Rauvolfia verticillata 90 grams, Radix Et Rhizoma Rhei 80 grams, 80 grams, mountain Pericarpium Citri Reticulatae Viride, Conyza canadensis (L.) Cronq. 30 grams and 800 grams, water, be placed in the flask of sealing, heat 3 hours under the water-bath of 80 DEG C, filter, collect filtrate, sterilizing and get final product.
Experimental example 1
1, clinical data
Patient 40 example after oral implant rehabilitation, man 20 example, female 20 example: 21 years old ~ 48 years old age.All surgically, postoperative wound suture, wound length is all less than 5 centimetres to all patients.
2, Therapeutic Method
Use collutory prepared by embodiment 1 after surgery, each 20ml that uses gargles.Every day 1 time.Continuous use 1 week.
3, therapeutic outcome
To have no lump in postoperative oral cavity, flicking wound has no in obvious pain, oral cavity does not have swelling sense for standard.By taking collutory of the present invention, find that all patients all meets above-mentioned standard.And their investigation is learnt, after operation in patients non-perception significantly feel sick etc. sensation.
Experimental example 2 In Vitro Bacteriostasis effect test
1. material
1.1 for examination strain
Staphylococcus aureus (Staphylococcus aureus) ATCC25923, Candida albicans (Candida albicans) ACTT12228, all purchased from Products in China calibrating institute.
1.2 culture fluid
Nutrient agar and nutrient broth, all purchased from Chen Yu experimental facilities company limited of BeiJing ZhongKe.1.3 test method
Staphylococcus aureus and Candida albicans are inoculated in agar plate nutritional solution plane, evenly gather during inoculation.The aseptic circular filter paper sheet of tweezer, uses the collutory of preparation in embodiment 1 to be squirted by filter paper, makes the drop of filter paper when vertically leaving standstill on it just start to drip.Filter paper is attached on the culture fluid of inoculated bacteria.Agar plate is placed in the incubator of 37 DEG C, incubation 24 hours.Measure the diameter of bacterial restrain.Measure and average for 3 times.
1.4 result
The average diameter of the bacterial restrain of staphylococcus aureus is 10.23mm, and the average diameter of the bacterial restrain of Candida albicans is 8.43mm, shows that collutory of the present invention has obvious fungistatic effect.
Claims (2)
1., for preventing a collutory for oral implant rehabilitation postoperative infection, it is characterized in that it is made up of the material of following weight proportioning: Cortex Meliosmatis rigidae Radicis 4 ~ 12 parts, 5 ~ 15 parts, Herba Spirodelae, Radix sidae acutae 3 ~ 15 parts, Herba Elsholtziae penduliforare 3 ~ 15 parts, Herba Taraxaci 4 ~ 12 parts, Herba Eupatorii Odorati 6 ~ 9 parts, Radix Wikstroemae 1 ~ 5 part, Rauvolfia verticillata 8 ~ 10 parts, Radix Et Rhizoma Rhei 7 ~ 10 parts, 7 ~ 9 parts, mountain Pericarpium Citri Reticulatae Viride, Conyza canadensis (L.) Cronq. 1 ~ 5 part and water 50-100 part.
2. collutory according to claim 1, is characterized in that it is made up of the material of following weight proportioning: Cortex Meliosmatis rigidae Radicis 8 parts, 10 parts, Herba Spirodelae, Radix sidae acutae 7 parts, Herba Elsholtziae penduliforare 7 parts, Herba Taraxaci 8 parts, Herba Eupatorii Odorati 7 parts, Radix Wikstroemae 3 parts, Rauvolfia verticillata 9 parts, Radix Et Rhizoma Rhei 8 parts, 8 parts, mountain Pericarpium Citri Reticulatae Viride, Conyza canadensis (L.) Cronq. 3 parts and 80 parts, water.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310521875.1A CN103520396B (en) | 2013-10-30 | 2013-10-30 | Mouthwash used for preventing infection after oral implant rehabilitation |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310521875.1A CN103520396B (en) | 2013-10-30 | 2013-10-30 | Mouthwash used for preventing infection after oral implant rehabilitation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103520396A CN103520396A (en) | 2014-01-22 |
| CN103520396B true CN103520396B (en) | 2015-07-08 |
Family
ID=49922983
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310521875.1A Expired - Fee Related CN103520396B (en) | 2013-10-30 | 2013-10-30 | Mouthwash used for preventing infection after oral implant rehabilitation |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103520396B (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103877223B (en) * | 2014-03-03 | 2015-09-30 | 青岛市市立医院 | A kind of pharmaceutical composition and application thereof for the treatment of oral candidiasis |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101057953A (en) * | 2006-04-21 | 2007-10-24 | 陈祖辉 | Multi-target cooperative control preparation for treating virus infectious disease |
-
2013
- 2013-10-30 CN CN201310521875.1A patent/CN103520396B/en not_active Expired - Fee Related
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101057953A (en) * | 2006-04-21 | 2007-10-24 | 陈祖辉 | Multi-target cooperative control preparation for treating virus infectious disease |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103520396A (en) | 2014-01-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104998153A (en) | Sterilization disinfectant for clinical laboratory and preparation method thereof | |
| CN108685996A (en) | It is a kind of to be used to prevent external natural pharmaceutical composition of acne and preparation method thereof | |
| CN102000197B (en) | Gargle for treating periapicalitis | |
| CN103961412B (en) | Traditional Chinese medicine composition as well as preparation method and application thereof | |
| CN103520396B (en) | Mouthwash used for preventing infection after oral implant rehabilitation | |
| CN105325649A (en) | Healthcare tea reducing blood glucose and preparation method thereof | |
| CN104971161A (en) | Application of vine tea extract in treatment of acnes | |
| CN104857413A (en) | Traditional Chinese medicine composition removing oral malodor and preparation method therefor | |
| CN105613612A (en) | Agent for disinfecting intensive care unit and preparation method | |
| CN114652748A (en) | Preparation method and application of medical gynecological lotion containing stem cell bacteriostatic factors | |
| CN103814968A (en) | Drug for sterilizing anaesthesia operating room | |
| CN105079000B (en) | A kind of composition and its application, preparation | |
| CN102579694B (en) | Mouthwash for preventing infection after oral surgery | |
| TWI727176B (en) | Use of pharmaceutical compositions in preparing pharmaceuticals for anti-helicobacter pylori | |
| CN101810666B (en) | Veterinary synergic enrofloxacin injection and preparation method thereof | |
| CN109248219A (en) | A kind of application of Chinese medicine composition in the drug of preparation treatment brickpox | |
| CN105663359B (en) | A kind of Chinese medicine composition and preparation method thereof for layer of green-shell egg In Vitro Bacteriostasis | |
| CN105028501A (en) | Disinfectant for pharmacy | |
| CN103285079B (en) | Preparation process of perfusion agent for treating dairy cow mastitis | |
| CN102670811B (en) | External medicament for treating bacterial vaginosis and colpitis mycotica | |
| CN102727577A (en) | Medicinal composition for treating gynecological inflammations | |
| CN1927260A (en) | Application of walnut oil in pharmaceutical preparation for preventing and treating osteoporosis | |
| CN105395538A (en) | Medicine composition treating acute upper respiratory infection | |
| CN106266159A (en) | A kind of for preoperative disinfectant solution | |
| Tsemenko et al. | STUDY OF THE UROANTISEPTIC ACTIVITY OF THE COMPLEX OF GLYCOSIDES OF PHENOLIC COMPOUNDS FROM LINGONBERRY LEAVES IN COMPLEX WITH THE ARGININE AMINO ACID. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20150708 Termination date: 20161030 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |